(Q64063254)

English

Activation of RIG-I signaling to increase the pro-inflammatory phenotype of a tumor

No description defined

In more languages

edit

Statements

0 references

0 references

Activation of RIG-I signaling to increase the pro-inflammatory phenotype of a tumor (English)

0 references

0 references

0 references

0 references

David L Elion

1

0 references

Rebecca S Cook

series ordinal

2

0 references

language of work or name

English

0 references

publication date

22 March 2019

0 references

published in

Oncotarget

0 references

volume

10

0 references

issue

24

0 references

page(s)

2338-2339

0 references

cites work

pH-Responsive nanoparticle vaccines for dual-delivery of antigens and immunostimulatory oligonucleotides

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/31040925

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The immune contexture in cancer prognosis and treatment

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/31040925

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Checkpoint inhibitors in breast cancer - Current status

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/31040925

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A minimal RNA ligand for potent RIG-I activation in living mice.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/31040925

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Checkpoint blockade in the treatment of breast cancer: current status and future directions

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/31040925

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytosolic DNA Sensing in Organismal Tumor Control

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/31040925

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutically Active RIG-I Agonist Induces Immunogenic Tumor Cell Killing in Breast Cancers

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/31040925

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.18632/ONCOTARGET.26729

0 references

PMC publication ID

6481327

0 references

PubMed publication ID

31040925

0 references

(Q64063254)

Activation of RIG-I signaling to increase the pro-inflammatory phenotype of a tumor

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)